Industry & Hardware
Cellbricks
Germany
seed
seed
Stage
1
Investors
About
Cellbricks develops a patented bioprinting process that enables manufacturing of in-vitro tissue models, personalized implants, and organ-replacement constructs by printing multiple cell types into tissue-like structures with integrated vascular systems.
Explore Cellbricks's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.